Products
Home » Products » Antibody » Primary Antibody » ER antibody
ER antibody
Category:
Research Area:
Synonyms: | DKFZp686N23123 antibody, ER antibody, ER alpha antibody, Era antibody, ESR antibody, ESR1 antibody, ESRA antibody, Estradiol receptor antibody, Estrogen receptor antibody, estrogen receptor 1 antibody, NR3A1 antibody | ||
Catalogue No.: | FNab02822 | Reativity: | Human, Mouse, Rat |
Host: | Rabbit | Tested Application: | ELISA, IHC, WB |
Clonality: | polyclonal | Isotype: | IgG |
- SPECIFICATIONS
- Product Name
- ER antibody
- Catalogue No.
- FNab02822
- Size
- 100μg
- Form
- liquid
- Purification
- Immunogen affinity purified
- Purity
- ≥95% as determined by SDS-PAGE
- Clonality
- polyclonal
- Isotype
- IgG
- Storage
- PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months (Avoid repeated freeze / thaw cycles.)
Immunogen
- Immunogen
- estrogen receptor 1
- Alternative Names
- DKFZp686N23123 antibody, ER antibody, ER alpha antibody, Era antibody, ESR antibody, ESR1 antibody, ESRA antibody, Estradiol receptor antibody, Estrogen receptor antibody, estrogen receptor 1 antibody, NR3A1 antibody
- UniProt ID
- P03372
- Observed MW
- 70 kDa
Application
- Tested Applications
- ELISA, IHC, WB
- Recommended dilution
- WB: 1:1000 - 1:4000; IHC: 1:50 - 1:200
Validated Images
hela cells were subjected to SDS PAGE followed by western blot with FNab02822( ER Antibody) at dilution of 1:1000
Immunohistochemistry of paraffin-embedded human breast cancer tissue using FNab02822(ESR1 antibody) at dilution of 1:100
- Background
- This gene encodes an estrogen receptor, a ligand-activated transcription factor composed of several domains important for hormone binding, DNA binding, and activation of transcription. The protein localizes to the nucleus where it may form a homodimer or a heterodimer with estrogen receptor 2. Estrogen and its receptors are essential for sexual development and reproductive function, but also play a role in other tissues such as bone. Estrogen receptors are also involved in pathological processes including breast cancer, endometrial cancer, and osteoporosis. Alternative promoter usage and alternative splicing result in dozens of transcript variants, but the full-length nature of many of these variants has not been determined.